COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,796 Articles (22,527 medRxiv, 8,269 bioRxiv)

Most recent first Previous |  Page 1537: Articles 15361-15370  | Next

Paradox of Predictors in Critically ill COVID-19 Patients: Outcome of a COVID-dedicated Intensive Care Unit
Nasir, M., Perveen, R. A., Nazneen, R., Zahan, T., Ahmad, S. N., Chowdhury, A. S.
10.1101/2021.04.23.21256009 — Posted: 2021-04-26
Developing RT-LAMP Assays for Detection of SARS-CoV-2 in Saliva
Huang, X., Tang, G., Ismail, N., Wang, X.
10.1101/2021.04.25.21256085 — Posted: 2021-04-26
Contrasting epidemiology and population genetics of COVID-19 infections defined with 74 polymorphic loci in SARS-CoV-2 genomes sampled globally.
Chan, F., Ataide, R., Richards, J. S., Narh, C. A.
10.1101/2021.04.25.21255897 — Posted: 2021-04-26
Patterns of SARS-CoV-2 Aerosol Spread in Typical Classrooms
Rencken, G. K., Rutherford, E. K., Ghanta, N., Kongoletos, J., Glicksman, L.
10.1101/2021.04.26.21256116 — Posted: 2021-04-26
Risk factors for long covid in previously hospitalised children using the ISARIC Global follow-up protocol: A prospective cohort study
Osmanov, I. M., Spiridonova, E., Bobkova, P., Gamirova, A., Shikhaleva, A., Andreeva, M., Blyuss, O., El-Taravi, Y., DunnGalvin, A., Comberiati, P., Peroni, D. G., Apfelbacher, C., Genuneit, J., Mazankova, L., Miroshina, A., Chistyakova, E., Samitova, E., Borzakova, S., Bondarenko, E., Korsunskiy, A. A., Konova, I., Hanson, S. W., Carson, G., Sigfrid, L., Scott, J. T., Greenhawt, M., Whittaker, E. A., Garralda, E., Swann, O., Buonsenso, D., Nicholls, D. E., Simpson, F., Jones, C., Semple, M. G., Warner, J. O., Vos, T., Olliaro, P., Munblit, D., Sechenov StopCOVID Research Team
10.1101/2021.04.26.21256110 — Posted: 2021-04-26
Is large-scale rapid CoV-2 testing a substitute for lockdowns? The case of Tuebingen
Diederichs, M., Kremsner, P., Mitze, T., Schulz, F., Mueller, G. J., Papies, D., Waelde, K.
10.1101/2021.04.26.21256094 — Posted: 2021-04-26 Discussion: Onsite
Conserved in 186 countries the RBD fraction of SARS CoV-2 S-protein with in-silicoT500S mutation strongly blocks ACE2 rejecting the viral spike; A Molecular-docking analysis.
Banerjee, A., Kanwar, M., Santra, D., Maiti, S.
10.1101/2021.04.25.441361 — Posted: 2021-04-26
A Novel Evidence-Based Predictor Tool for Hospitalization and Length of Stay: Insights from COVID19 Patients in New York City
El Halabi, M., Feghali, J., Tallon de Lara, P., Narasimhan, B., Ho, K., Saabeyi, J., Huang, J., Osorio, G., Mathew, J., Wisnivesky, J., Steiger, D.
10.1101/2021.04.24.21256042 — Posted: 2021-04-26
Insertions in SARS-CoV-2 genome caused by template switch and duplications give rise to new variants of potential concern
Garushyants, S. K., Rogozin, I. B., Koonin, E. V.
10.1101/2021.04.23.441209 — Posted: 2021-04-26
Analysis of viral RNA-host protein interactomes enables rapid antiviral drug discovery
Zhang, S., Huang, W., Ren, L., Ju, X., Gong, M., Rao, J., Sun, L., Li, P., Ding, Q., Wang, J., Zhang, Q. C.
10.1101/2021.04.25.441316 — Posted: 2021-04-26

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).